Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Inderberg, Else Marit
[Clear All Filters]
2023
Mensali N
,
Köksal H
,
Joaquina S
,
Wernhoff P
,
Casey NP
,
Romecin P
,
Panisello C
,
Rodriguez R
,
Vimeux L
,
Juzeniene A
, et al.
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Nat Commun. 2023;14(1):3375.
PubMed
Google Scholar
Fløisand Y
,
Remberger M
,
Bigalke I
,
Josefsen D
,
Vålerhaugen H
,
Inderberg EMarit
,
Olaussen RW
,
Gjertsen BTore
,
Goedkoop R
,
Geiger C
, et al.
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.
Leukemia. 2023.
PubMed
Google Scholar
2020
Dillard P
,
Köksal H
,
Maggadottir SMelkorka
,
Winge-Main A
,
Pollmann S
,
Menard M
,
Myhre MRenée
,
Mælandsmoe GM
,
Flørenes VAnn
,
Gaudernack G
, et al.
Targeting telomerase with an HLA class II-restricted TCR for cancer immunotherapy.
Mol Ther. 2020.
PubMed
Google Scholar